Gene: SLTM
Official Full Name: SAFB like transcription modulatorprovided by HGNC
Gene Summary: Enables RNA binding activity. Predicted to be involved in regulation of mRNA processing and regulation of transcription by RNA polymerase II. Located in nuclear body. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13971 | SLTM Knockout cell line (HeLa) | Human | SLTM | 1:3~1:6 | Negative | Online Inquiry |
KO13972 | SLTM Knockout cell line (HCT 116) | Human | SLTM | 1:2~1:4 | Negative | Online Inquiry |
KO13973 | SLTM Knockout cell line (HEK293) | Human | SLTM | 1:3~1:6 | Negative | Online Inquiry |
KO13974 | SLTM Knockout cell line (A549) | Human | SLTM | 1:3~1:4 | Negative | Online Inquiry |
SLTM Gene Knockout Cell Lines are state-of-the-art cellular models specifically designed for the targeted disruption of the SLTM gene, a key player in cellular processes such as transcription regulation and cellular differentiation. These cell lines serve as invaluable tools for researchers seeking to explore the functional role of SLTM in various biological pathways and disease contexts. The knockout mechanism is achieved through CRISPR-Cas9 technology, providing a precise and efficient method to create gene alterations with minimal off-target effects.
The primary function of SLTM Gene Knockout Cell Lines is to enable the study of gene function and its impact on cellular phenotypes. By facilitating the examination of the resultant gene expression changes, protein interactions, and downstream signaling pathways, these cell lines can significantly enhance our understanding of the molecular mechanisms underpinning various diseases, including cancer, neurodegenerative disorders, and metabolic syndromes. In clinical settings, these models can aid in drug discovery and development, allowing for the screening of therapeutic compounds targeting SLTM-associated pathways.
One of the standout advantages of our SLTM Gene Knockout Cell Lines is their high specificity and reliability compared to traditional knockdown methods such as RNA interference. Unlike transient knockdown approaches, which can lead to inconsistent results, our knockout models provide stable gene disruptions, enabling long-term studies of gene function and therapeutic efficacy. Furthermore, these cell lines come with extensive characterization data, allowing researchers to confidently interpret experimental outcomes.
The value of SLTM Gene Knockout Cell Lines to researchers and clinicians cannot be overstated. By offering a robust platform for investigating gene function, these cell lines accelerate the pace of discovery and provide insights that could lead to transformative therapies. Researchers can rely on our carefully validated products to drive their studies forward with greater confidence and reproducibility.
With a commitment to scientific excellence, our company specializes in providing high-quality biological products optimized for research and clinical applications. Our expertise ensures that users receive not only superior cell lines but also comprehensive technical support to enhance their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.